Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 18%
Hold 45%
Sell 9%
Strong Sell 0%

Bulls say

Universal Health Services has demonstrated strong financial growth, with its acute care segment achieving a same-store sales revenue increase of 12.8% and an adjusted EBITDA margin expansion of 190 basis points to 15.8%. The behavioral health segment has shown resilience and growth potential, with same-store revenue rising by 9.3% and improved patient volumes, indicating a positive trend for future performance. Additionally, anticipated CMS program approvals could yield an estimated benefit of $75-80 million, further enhancing the company’s financial outlook as it effectively manages costs and capacity expansions.

Bears say

Universal Health Services is facing a negative outlook due to anticipated volume and margin headwinds, which are expected to lead to earnings approximately 5% below earlier estimates for FY26, with an enterprise multiple projected at around 5.5x, reflecting trough levels seen in 2024. The company's behavioral health volumes are projected to trend at just 2% in 2026, following an adjustment in its long-term outlook, and significant concerns remain regarding the decline of the DPP contribution to EBITDA, which is expected to impact earnings by $420-470 million over the 2028-2032 period. Additional risks include concentration in the Las Vegas market, potential regulatory changes affecting healthcare policies, and a tightening labor supply that could further pressure productivity and margins in urban areas.

UHS has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 18% recommend Buy, 45% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 11 analysts, UHS has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $233, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $233, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.